510(k) K960257
K960257 is an FDA 510(k) premarket notification submitted by Behring Diagnostics, Inc. for the device "N ANTISERUM TO C1 INHIBITOR". The FDA issued a decision of Substantially Equivalent on August 1, 1996. The device falls under product code DBA (Complement C1 Inhibitor (Inactivator), Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5250. Behring Diagnostics, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 1, 1996
- Date Received
- January 18, 1996
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Complement C1 Inhibitor (Inactivator), Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5250
- Review Panel
- IM
- Submission Type